Insight
Milestones
Defined by success.
A view into our company's milestones reflects our passion, energy and resourcefulness in creating positive outcomes. We're known for developing innovative concepts that redefine deep tech and biopharma. A number of our ventures are recognized for their global impact. See how we have inspired and reached new markets, empowering a new generation of businesses leaders.
Defined by success.
A view into our company's milestones reflects our passion, energy and resourcefulness in creating positive outcomes. We're known for developing innovative concepts that redefine deep tech and biopharma. A number of our ventures are recognized for their global impact. See how we have inspired and reached new markets, empowering a new generation of businesses leaders.
2023
Created Bridgewest India, our first Global Capability Center and first company in India
Acquired Pfizer plant in Perth Australia and formed NovaCina, our first Sterile Injectable CDMO and LumaCina, our first Sterile Injectable Drug Products.
2022
Chiplet solutions company Wavious is acquired by a Fortune 5 company.
2021
Bridgewest Ventures New Zealand (BVNZ) makes first incubator investments in New Zealand.
Bridgewest Tranquility Holdings formed for real estate investments in Europe.
2020
BioAtla (BCAB) initial public offering on NASDAQ, $1 billion+
Our first Australian drug manufacturing facility. Acquired Pfizer's plant and formed BioCina.
BioDuro combines with Sundia to create world's 3rd largest CRDMO.
Skyriver Spectrum & Technology sells 5G assets to leading U.S wireless carriers.
2019
New Zealand Government partners with BVNZ to operate deep tech incubator program.
Created our first SaaS companies - SuiteFiles, Projectworks.
Our first New Zealand company is acquired - Provoke Solutions.
Bridgewest Group sells majority stake in BioDuro - Advent becomes majority investor.
2017
Acquired our first New Zealand commercial real estate.
2016
New Zealand market expansion with formation of Bridgewest Finance NZ.
2015
Molecular Response sells its Patient-Derived Xenograft (PDX) business to Crown Bioscience.
2014
Iconic San Diego Innovation Center property in San Diego acquired.
Endura formed, our first entry into AI.
2012
Expansion into Specialty Commercial property - biotech/medical.
2011
First 5G deployment via Skyriver Communications' proprietary technology.
Qualcomm acquires Rapid Bridge, inventor of advanced techniques for design and development of semiconductors.
Created Bridgewest Capital to spearhead and operationalize our global eco-community.
2010
Molecular Response created largest living tumor bank.
Single family residential property portfolio acquired.
2005
BioDuro marks our first entry into pharmaceutical services and first bio tech company in China.
Expansion into Biopharma with formation of Biotech Investment Group.
2000
Our first venture capital investments made, including Skyriver Communications.
1999
WFI Initial Public Offering is one of largest and most successful offerings of the year, with global operations in 60 countries.
